Prolonged weakness after long-term infusion of vecuronium bromide.
Kupfer
Y
Y
Maimonides Medical Center, Brooklyn, New York.
Namba
T
T
Kaldawi
E
E
Tessler
S
S
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011446:Prospective Studies; D012131:Respiratory Insufficiency / Q000628:therapy; D013997:Time Factors; D014673:Vecuronium Bromide / Q000008:administration & dosage / Q000009:adverse effects*
D014673:Vecuronium Bromide